Atropine sulfate ophthalmic (Sydnexis)

硫酸阿托品眼药水滴眼液 (Sydnexis)

Report date: 2025/12/15 20:00:38

Base Information

Drug NameAtropine sulfate ophthalmic (Sydnexis)
Drug Alias NameRyjuneaRyjusea MiniSTN-1012701SYD-101STN1012701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsMyopia
Global Approved IndicationsMyopia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2024/12/27
Country/TerritoryUnited StatesSlovakiaAustria +[6
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSydnexis Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyopia
Inactive IndicationsN/A

Other Information

ATC CodeS01FA01
Related LinksN/A